BioAtla Return on Equity (ROE) Growth & History (BCAB)
BioAtla's return on equity was −164.30% for fiscal 2024.
View full BioAtla company overviewBioAtla annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −164.30% | −65.93 pp |
| 2023 | 2023-12-31 | −98.37% | −43.93 pp |
| 2022 | 2022-12-31 | −54.44% | −9.10 pp |
| 2021 | 2021-12-31 | −45.34% | +1.23 pp |
| 2020 | 2020-12-31 | −46.57% | — |
BioAtla quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −207.05% | −168.45 pp |
| Q4 2024 | 2024-12-31 | −79.95% | −47.39 pp |
| Q3 2024 | 2024-09-30 | −38.96% | −8.56 pp |
| Q2 2024 | 2024-06-30 | −51.97% | −26.52 pp |
| Q1 2024 | 2024-03-31 | −38.60% | −22.29 pp |
| Q4 2023 | 2023-12-31 | −32.56% | −15.51 pp |
| Q3 2023 | 2023-09-30 | −30.40% | −13.64 pp |
| Q2 2023 | 2023-06-30 | −25.45% | −9.17 pp |
| Q1 2023 | 2023-03-31 | −16.31% | −4.21 pp |
| Q4 2022 | 2022-12-31 | −17.06% | −6.46 pp |
| Q3 2022 | 2022-09-30 | −16.76% | −5.54 pp |
| Q2 2022 | 2022-06-30 | −16.28% | −0.04 pp |
| Q1 2022 | 2022-03-31 | −12.10% | −2.89 pp |
| Q4 2021 | 2021-12-31 | −10.60% | +10.70 pp |
| Q3 2021 | 2021-09-30 | −11.22% | — |
| Q2 2021 | 2021-06-30 | −16.25% | — |
| Q1 2021 | 2021-03-31 | −9.21% | — |
| Q4 2020 | 2020-12-31 | −21.30% | — |
BioAtla return on equity trends
Between the periods ended 2020-12-31 and 2024-12-31, BioAtla's return on equity decreased from −46.57% to −164.30%, a change of −117.73 percentage points. The latest reported quarter, Q1 2025, shows −207.05%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioAtla source filings ↗